Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Coeptis Therapeutics
Coeptis Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Coeptis Therapeutics
Stock Price
$0.2
2024-10-29
Market Capitalization
$8.3 M
2024-10-29
Coeptis Therapeutics Summary
Company Summary
Overview
Coeptis Therapeutics (also known as Coeptis Therapeutics Holdings) is a biopharmaceutical company that specializes in cancer treatment solutions. It develops an allogeneic cell therapy platform for treating cancer and other debilitating diseases.
Type
Public
Status
Active
Founded
2017
Website
https://coeptistx.com/
Cybersecurity rating
Sectors
Healthcare
holding company
oncology
pharma
therapy
Homepage
Linkedin
twitter
Table of Contents
Competitors
Competitors and Similar Companies
Seagen
Healthcare - Subsidiary
Mallinckrodt Pharmaceuticals
Healthcare - Private
Opsy
Healthcare - Public
Legend Biotech
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top